PODLOGAR SUSAN M

Director · LIVN

As of 2026-09-16, PODLOGAR SUSAN M has 12 Form 4 transactions on record across 1 company — 9 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $187KIndirect: $0$187Kas of 2026-09-16
  • Direct $187K
  • Indirect $0
LIVNdirect2,383 sh$187K

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

LIVN · 9 trades
2026-06-15: Withheld for tax, 486 sh ($39K)2026-06-15: Option exercise, 4,042 sh ($0)2026-06-15: Option exercise, 4,042 sh ($0)2026-06-15: Award / grant, 2,383 sh ($0)2025-12-15: Withheld for tax, 269 sh ($17K)2025-12-15: Option exercise, 2,355 sh ($0)2025-12-15: Option exercise, 2,355 sh ($0)2025-06-15: Award / grant, 4,042 sh ($0)2024-12-15: Award / grant, 2,355 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
12 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-09-11Award / grant75,000123,678Form 4
2026-07-10Award / grant40,00048,678Form 4
2026-06-15LIVNWithheld for tax4865,642Form 4
2026-06-15LIVNOption exercise4,0426,128Form 4
2026-06-15LIVNOption exercise4,0420Form 4
2026-06-15LIVNAward / grant2,3832,383Form 4
2025-12-15LIVNWithheld for tax2692,086Form 4
2025-12-15LIVNOption exercise2,3552,355Form 4
2025-12-15LIVNOption exercise2,3550Form 4
2025-06-15LIVNAward / grant4,0424,042Form 4
2024-12-23Award / grant240,000433,923Form 4
2024-12-15LIVNAward / grant2,3552,355Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.